Global Hospital-Acquired Infection Treatment Market Size, Report, Forecast 2023-2031
Author : sophia grace | Published On : 11 May 2023
The ‘Global Hospital-Acquired Infection Treatment Market Size, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global hospital-acquired infection treatment market, assessing the market on the basis of its segments like product and services, infection type, applications, end user, and major regions.
The report also provides a detailed insight of the market based on patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnership and collaborations analysis.
The key highlights of the report include:
Market Overview (2016-2031)
- Historical Value (2022): USD 15.31 Billion
- Forecast CAGR (2023-2031): 4.2%
- Forecast Value (2031): USD 20.07 Billion
The global hospital-acquired infection treatment market is expected to witness significant growth due to the increasing prevalence of hospital-acquired infections (HAIs), advancements in healthcare facilities, and growing awareness about the importance of maintaining a sterile hospital environment. Additionally, the rising demand for effective infection control measures and the development of novel therapies are expected to drive the market growth. However, factors such as stringent regulatory requirements and the high cost of treatments may hamper the market growth.
Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/hospital-acquired-infection-treatment-market/requestsample
The increasing adoption of antimicrobial coatings on medical devices and the development of advanced sterilization technologies are expected to further boost the market growth. Moreover, the growing focus on the implementation of strict guidelines for the prevention of HAIs will contribute to the expansion of the hospital-acquired infection treatment market.
Industry Definition and Major Segments
Hospital-acquired infections, also known as nosocomial infections, are infections that patients contract while receiving treatment for other medical or surgical conditions within a healthcare setting. These infections can be caused by bacteria, viruses, or fungi and can lead to serious complications, prolonged hospital stays, and increased healthcare costs. The hospital-acquired infection treatment market encompasses various methods and therapies for the prevention, diagnosis, and treatment of these infections.
The market is segmented based on products and services method into:
- Cleaning and Disinfection Products
- Endoscope Reprocessing Products
- Protective Barriers
Based on infection type, the market is classified into:
- Hospital-acquired Pneumonia
- Bloodstream Infections
- Surgical Site Infections
- Urinary Tract Infections (UTIs)
Based on application, the market is bifurcated into:
- Drug-Resistance Testing
- Disease Testing
Based on end user, the market is bifurcated into:
- Hospitals and ICUs
- Ambulatory Surgical Centres
- Nursing Homes and Maternity Centres
Based on region, the market is segregated into:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The key trends in the global hospital-acquired infection treatment market include the development of new drugs and therapies, the increasing use of antimicrobial coatings on medical devices, and the implementation of strict infection prevention and control measures in healthcare settings. The adoption of advanced sterilization technologies, such as hydrogen peroxide vapor, ultraviolet light, and ozone sterilization, is also expected to contribute to the market growth.
Additionally, the increasing focus on research and development for the discovery of new antimicrobial agents and the growing awareness about the need for maintaining a clean and sterile environment in hospitals and other healthcare facilities are expected to drive the demand for hospital-acquired infection treatment solutions.
Key Market Players
The major players in the global hospital-acquired infection treatment market report are Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, Bayer AG, AstraZeneca plc, F. Hoffmann-La Roche Ltd, and Becton, Dickinson and Company, among others. The report covers the market shares, capacities, plant turnarounds expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
The report studies the latest updates in the market, along with their impact across the market. It also analyzes the market demand, together with its price and demand indicators. The report also tracks the market based on SWOT and Porter’s Five Forces Models.